{"id":"https://openalex.org/W2249014580","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","title":"Acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) and overall mortality with chemotherapy (CT) and granulocyte colony-stimulating factor (G-CSF): A meta-analysis of randomized controlled trials (RCTs)","display_name":"Acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) and overall mortality with chemotherapy (CT) and granulocyte colony-stimulating factor (G-CSF): A meta-analysis of randomized controlled trials (RCTs)","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2249014580","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","mag":"2249014580"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.9524","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2249014580"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073060840","display_name":"Gary H. Lyman","orcid":"https://orcid.org/0000-0002-0823-8086","observed_orcids":["https://orcid.org/0000-0002-0823-8086"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. H. Lyman","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112121278","display_name":"DC Dale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. C. Dale","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090143035","display_name":"Eva Culakova","orcid":"https://orcid.org/0000-0002-9852-6515","observed_orcids":["https://orcid.org/0000-0002-9852-6515"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Culakova","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112254865","display_name":"Marek S. Poniewierski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. S. Poniewierski","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112997246","display_name":"D. A. Wolff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Wolff","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062529227","display_name":"N. M. Kuderer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. M. Kuderer","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Lambert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Lambert","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001543309","display_name":"JJ Crawford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Crawford","raw_affiliation_strings":["Duke University, Durham, NC; University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0348,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.04435107,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"9524","last_page":"9524"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.8726000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.1160999983549118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.40700000524520874},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.7649999856948853},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9409999847412109},{"id":"https://openalex.org/keywords/dose-dense-chemotherapy","display_name":"dose-dense chemotherapy","score":0.9679999947547913},{"id":"https://openalex.org/keywords/relative-dose-intensity","display_name":"relative dose intensity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.7480000257492065},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6269999742507935},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/chemotherapy-induced-myelosuppression","display_name":"chemotherapy-induced myelosuppression","score":0.5040000081062317},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.578000009059906},{"id":"https://openalex.org/keywords/allogeneic-transplantation","display_name":"allogeneic transplantation","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9546314477920532},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7115283608436584},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6145697832107544},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5658228993415833},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5484387278556824},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5301347970962524},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5190333127975464},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.41974085569381714},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4175850450992584},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25527042150497437},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.11064004898071289}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.9524","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.9524","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000253139","https://openalex.org/W2558521888","https://openalex.org/W2993305496","https://openalex.org/W2329974252","https://openalex.org/W1514782697","https://openalex.org/W2589639128","https://openalex.org/W3150581177","https://openalex.org/W1576941798","https://openalex.org/W2970603565","https://openalex.org/W2557923662"],"abstract_inverted_index":{"9524":[0],"Background:":[1],"To":[2],"evaluate":[3],"the":[4,151,188,218,277,299],"risk":[5,85,89,285,300],"of":[6,19,39,140,177,241,254,286,296,301],"AML/MDS":[7,57,75,128,145,242,255,302],"and":[8,55,76,87,118,121,162,199,211,233,249,283],"overall":[9,270],"mortality":[10,168,182,235,244,282],"in":[11,116,146,183,213,239,269,281],"patients":[12,44,103],"receiving":[13],"CT":[14,47,107,308],"\u00b1":[15,48,108],"G-CSF,":[16,123],"a":[17],"meta-analysis":[18],"RCTs":[20,38],"were":[21,74,92,104,114,157,194,208,245],"conducted.":[22],"Methods:":[23],"Electronic":[24],"databases":[25],"searched":[26],"through":[27],"August":[28],"2008":[29],"identified":[30],"3,794":[31],"articles":[32],"for":[33,127,144,167,181],"initial":[34],"screening.":[35],"Eligibility":[36],"included":[37],"solid":[40],"tumor":[41],"or":[42,58,69,154,191,221,243],"lymphoma":[43],"randomized":[45,105],"to":[46,106,132,149,186,216,292,306],"primary":[49,109],"G-CSF":[50,110,297],"support,":[51],"\u22652":[52],"years":[53],"follow-up":[54,98],"reporting":[56],"all":[59],"second":[60],"malignancies.":[61],"Pre-specified":[62],"study":[63,147,184],"categories":[64,148,185],"included:":[65],"a)same":[66],"dose/schedule,":[67],"b)dose-dense":[68],"c)dose-escalated":[70],"CT.":[71],"Primary":[72],"outcomes":[73],"mortality.":[77,271],"Dual":[78],"blinded":[79],"data":[80],"extraction":[81],"was":[82,99,134,171,228],"performed.":[83],"Relative":[84],"(RR)":[86],"absolute":[88],"difference":[90],"(ARD)":[91],"estimated":[93],"by":[94],"Mantel-Haenszel.":[95],"Results:":[96],"Median":[97],"54":[100],"months.":[101],"12,642":[102],"support.":[111],"Second":[112],"malignancies":[113],"reported":[115],"3.3%":[117,178],"3.2%":[119],"with":[120,129,137,169,174,258,266,276],"without":[122],"respectively":[124],"(P=.942).":[125],"RR":[126,143,166,180,279],"CT+G-CSF":[130,156,170,193,263],"compared":[131],"control":[133],"1.92":[135],"[P=.006]":[136],"ARD":[138,175],"increase":[139],"0.4%":[141],"[P=.008].":[142],"receive":[150,187,217],"same,":[152,189,219],"dose-dense":[153,190,220],"dose-escalated":[155,192,222],"1.95":[158],"[P=.346],":[159],"1.20":[160],"[P=.666]":[161],"2.47":[163],"[P=.006],":[164],"respectively.":[165,202,224],"0.898":[172],"[P<.0001]":[173],"decrease":[176],"[P<.0001].":[179],"0.95":[195],"[P=.140],":[196],"0.84":[197],"[P<.001]":[198],"0.91":[200],"[P=.019],":[201],"Delivered":[203],"relative":[204],"dose":[205,259],"intensities":[206],"(RDI)":[207],"1.18,":[209],"1.46":[210],"1.23":[212],"studies":[214],"planned":[215],"CT,":[223],"A":[225],"significant":[226],"association":[227],"observed":[229,246],"between":[230,247],"delivered":[231],"RDI":[232],"reduced":[234],"[P=.013].":[236],"No":[237],"differences":[238],"estimates":[240],"industry":[248],"non-industry-funded":[250],"studies.":[251],"Conclusions:":[252],"Risk":[253],"is":[256,264,290],"increased":[257,307],"escalated":[260],"CT+G-CSF.":[261],"Nevertheless,":[262],"associated":[265,275],"greater":[267],"reductions":[268],"Dose-dense":[272],"regimens":[273],"are":[274],"greatest":[278],"reduction":[280],"lowest":[284],"AML/MDS.":[287],"Further":[288],"research":[289],"needed":[291],"differentiate":[293],"any":[294],"impact":[295],"on":[298],"from":[303],"that":[304],"due":[305],"intensity.":[309],"[Table:":[310],"see":[311],"text]":[312]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2249014580","counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2016-06-24T00:00:00"}
